This Month in Psychopharmacology

Effectiveness of Antidepressant Treatments In TRD

A comprehensive network meta-analysis recently published offers new...

Read More

The Role of Inflammation in Mental Health

Inflammation triggers chemical reactions in the body that can direc...

Read More

Medication-Induced Weight Change Across Common Antidepressant Treatments

While antidepressants rank among the most frequently prescribed dru...

Read More

Inflammatory Biomarkers and Risk of Psychiatric Disorders

A recent study investigates whether certain inflammatory markers i...

Read More

Poor Sleep Associated with Poorer Antidepressant Response

Poor sleep is common in treatment-resistant late-life depression an...

Read More

Esketamine versus Quetiapine Extended Release in Adults with TRD

A recent study compared the adverse effects and overall safety of e...

Read More

TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

The FDA has recently granted clearance of a transcranial magnetic s...

Read More

Positive Phase 3 Topline Results Evaluating Lumateperone as Adjunctive Therapy for MDD

Encouraging results from a Phase 3 clinical trial evaluating lumate...

Read More

Highlights from 2024 NEI Synapse: The Road Forward: Guidelines for the Detection and Management of Treatment-Resistant Depression

Major depressive disorder (MDD) can be difficult to treat and if pa...

Read More

Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding

A recent population-based, nested case-control study assessed wheth...

Read More

FDA Clears First Prescription Digital Therapeutic Authorized for Treatment of MDD

The FDA has cleared the first prescription digital therapeutic auth...

Read More

Pharmacological Treatments for Psychotic Depression

Current treatment guidelines for psychotic depression recommend a c...

Read More